Genomic Health, Inc. (GHDX) Reports Q4 loss of 30c, Offers Guidance

February 4, 2014 4:30 PM

Genomic Health, Inc. (NASDAQ: GHDX) reported Q4 EPS of ($0.30), $0.27 worse than the analyst estimate ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found